Skip to main content
Gennady Bratslavsky, MD, Urology, Syracuse, NY

Gennady Bratslavsky MD


Professor and Chair of Urology Division Chief of Upstate Urology at 550 Harrison Division Chief of Urologic Male Health Director of Prostate Cancer Program Department Chief of Adult Urology Clinic Department Chief of Urologic Oncology SUNY Upstate Medica

Join to View Full Profile
  • 750 E Adams StSyracuse, NY 13210

  • Phone+1 315-464-6106

  • Fax+1 315-464-6117

Dr. Bratslavsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Albany Medical Center
    Albany Medical CenterResidency, Urology, 2000 - 2005
  • Albany Medical College
    Albany Medical CollegeClass of 2000

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - 2026
  • PA State Medical License
    PA State Medical License 2013 - 2018
  • VA State Medical License
    VA State Medical License 2005 - 2012
  • Urology
    American Board of Urology Urology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • Malignant pheochromocytoma (MP): A comprehensive genomic profiling (CGP) study. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • PBRM1Â mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Join now to see all

Press Mentions

  • Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in the Lancet Oncology
    Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in the Lancet OncologyNovember 30th, 2020
  • Upstate Professors to Present at International Cancer Conference in Spain
    Upstate Professors to Present at International Cancer Conference in SpainSeptember 27th, 2019
  • Cytoreductive Nephrectomy May Benefit RCC Patients with Brain Mets
    Cytoreductive Nephrectomy May Benefit RCC Patients with Brain MetsDecember 12th, 2018
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: